X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA GSK PHARMA SHASUN PHARMA/
GSK PHARMA
 
P/E (TTM) x 123.9 64.6 191.7% View Chart
P/BV x 8.5 10.4 82.2% View Chart
Dividend Yield % 0.2 1.2 19.1%  

Financials

 SHASUN PHARMA   GSK PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
GSK PHARMA
Mar-17
SHASUN PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs943,838 2.5%   
Low Rs462,637 1.7%   
Sales per share (Unadj.) Rs214.2354.2 60.5%  
Earnings per share (Unadj.) Rs5.339.8 13.4%  
Cash flow per share (Unadj.) Rs15.842.9 36.9%  
Dividends per share (Unadj.) Rs1.0030.00 3.3%  
Dividend yield (eoy) %1.40.9 154.4%  
Book value per share (Unadj.) Rs53.3236.9 22.5%  
Shares outstanding (eoy) m56.6284.70 66.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.39.1 3.6%   
Avg P/E ratio x13.181.4 16.1%  
P/CF ratio (eoy) x4.475.5 5.9%  
Price / Book Value ratio x1.313.7 9.6%  
Dividend payout %18.775.4 24.8%   
Avg Mkt Cap Rs m3,958274,216 1.4%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m2,1644,830 44.8%   
Avg. sales/employee Rs ThNM6,387.0-  
Avg. wages/employee Rs ThNM1,028.3-  
Avg. net profit/employee Rs ThNM717.1-  
INCOME DATA
Net Sales Rs m12,12730,000 40.4%  
Other income Rs m229728 31.5%   
Total revenues Rs m12,35630,728 40.2%   
Gross profit Rs m1,0094,190 24.1%  
Depreciation Rs m594263 225.7%   
Interest Rs m4150-   
Profit before tax Rs m2304,655 4.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m-731,744 -4.2%   
Profit after tax Rs m3023,368 9.0%  
Gross profit margin %8.314.0 59.6%  
Effective tax rate %-31.737.5 -84.5%   
Net profit margin %2.511.2 22.2%  
BALANCE SHEET DATA
Current assets Rs m6,88416,742 41.1%   
Current liabilities Rs m8,4567,202 117.4%   
Net working cap to sales %-13.031.8 -40.8%  
Current ratio x0.82.3 35.0%  
Inventory Days Days6252 119.0%  
Debtors Days Days10821 517.5%  
Net fixed assets Rs m4,9708,635 57.6%   
Share capital Rs m113847 13.4%   
"Free" reserves Rs m2,87519,222 15.0%   
Net worth Rs m3,02020,069 15.0%   
Long term debt Rs m1,81710 18,174.0%   
Total assets Rs m13,34730,038 44.4%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.60 120,762.2%  
Sales to assets ratio x0.91.0 91.0%   
Return on assets %5.411.2 47.9%  
Return on equity %10.016.8 59.6%  
Return on capital %13.325.5 52.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,843528 1,106.6%   
Fx outflow Rs m2,1737,193 30.2%   
Net fx Rs m3,669-6,665 -55.1%   
CASH FLOW
From Operations Rs m3982,360 16.8%  
From Investments Rs m-1,6353,008 -54.4%  
From Financial Activity Rs m1,309-5,108 -25.6%  
Net Cashflow Rs m71260 27.4%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.6 10.2 35.3%  
FIIs % 17.6 23.8 73.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 15.4 257.1%  
Shareholders   20,750 102,036 20.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  NOVARTIS  PANACEA BIOTECH  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS